PREVIOUS
✖
Personalized mRNA vaccine for melanoma
May 1 , 2024
549 days
708
0
- Doctors have started the trials on hundreds of patients for the world's first personalised mRNA cancer vaccine for melanoma.
- Melanoma, the leading cause of skin cancer deaths globally, affects approximately 132,000 people annually.
- The vaccine, called mRNA-4157 (V940), is a personalised treatment that activates the immune system to fight a patient's specific cancer.
- It targets tumour neoantigens, which are unique markers found on tumours and can be recognised by the immune system.
Leave a Reply
Your Comment is awaiting moderation.